Esophagitis, Peptic clinical trials

The registry lists 83 studies for Esophagitis, Peptic across more than 10 countries. 16 are recruiting or about to start. 53 of them are mainly about Esophagitis, Peptic (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-23.

Get an email when these change. Save the Esophagitis, Peptic studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 50
Status unknown: 10
Not yet recruiting: 9
Recruiting: 7
Terminated: 4
Suspended: 1

Phase

Phase 3: 19
Phase 4: 9
Phase 2: 7
Phase 1: 7

Where

China: 18
Japan: 16
United States: 14
Korea, Republic of: 8
United Kingdom: 5
Canada: 5

Who runs them

AstraZeneca (12) · Takeda (10) · Trio Medicines Ltd. (4) · National Taiwan University Hospital (3) · Jiangsu Sinorda Biomedicine Co., Ltd (3) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (2) · Seoul National University Bundang Hospital (2) · Eisai Co., Ltd. (2)

What is being tested here

Drugs under test in Esophagitis, Peptic studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Esomeprazole	1	3	6
Dexlansoprazole	0	5	6
YF 476	0	0	4
D961H	0	2	3
Linaprazan glurate	0	1	3
Rabeprazole	0	1	3
Omeprazole	0	0	3
Lansoprazole	0	0	2
Fexuprazan	0	1	1
Chlorhexidine gluconate	0	0	1

Drug classes tested here Proton pump inhibitors (PPIs) 1 open

Coming up

2phase 3 studies under way

2studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 2

Dec 2026Feasibility and Safety of Robotic Assisted Proximal Gastrectomy With Double-flap Technique for Proximal Early Gastric Cancer · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Jun 2027Sino-Russian Comparison of Outcomes After Proximal Gastrectomy With Double-Tract Reconstruction · The First Affiliated Hospital with Nanjing Medical University

Who these studies take

Of the 7 Esophagitis, Peptic studies recruiting now, 3 (43%) set no upper age limit and 3 (43%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 7
Age	Women	Men
10	0 (0%)	0 (0%)
18	5 (71%)	5 (71%)
30	7 (100%)	7 (100%)
40	7 (100%)	7 (100%)
50	7 (100%)	7 (100%)
65	7 (100%)	7 (100%)
75	7 (100%)	7 (100%)
85	3 (43%)	3 (43%)

Across all 83 studies, recruiting or not: 42% stop at 75 or younger and 17% at 65; 14% take children; 0% are for women only and 5% for men only; 20% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 13, 2026.

Newly registered1

SPADE Clinical Trial.Oct 23, 2026NCT07892183

Studies

Recruiting first, then most recently updated. Showing 50 of 83. Browse all 83 → or search them.